fbpx
September 22, 2021

Nearly Half of HIV PrEP Descovy Switches Contraindicated Nearly Half of HIV PrEP Descovy Switches Contraindicated

George Froehle, PA, a primary care clinician at CentraCare in rural St. Cloud, Minnesota, has been prescribing the HIV prevention pill tenofovir disoproxil fumarate plus emtracitabine […]
September 21, 2021

COVID-19 Causes Major Interruption in Global HIV Progress COVID-19 Causes Major Interruption in Global HIV Progress

From testing to treatment, Global Fund HIV services have been hampered by COVID-19. “We’ve been set back by COVID but we’ve seen remarkable resilience, a lot […]
September 16, 2021

Realigned US HIV Panel Works to Rebuild Community Bridges Realigned US HIV Panel Works to Rebuild Community Bridges

In August, when Assistant Secretary for Health Rachel Levine swore in eight new members to the President’s Advisory Council on HIV/AIDS (PACHA), the U.S.’s most influential […]
September 16, 2021

How Black Women Have Fought the HIV Epidemic for Decades How Black Women Have Fought the HIV Epidemic for Decades

The Black women members of the President’s Advisory Council on HIV/AIDS (PACHA) are far from the first to bring their expertise to the HIV epidemic, as […]
September 3, 2021

HIV Vaccine Fails, Prompting Calls for More PrEP HIV Vaccine Fails, Prompting Calls for More PrEP

Last year, Katherine Gill, MD, an HIV prevention researcher in Cape Town, South Africa, realized how jaded she’d become to vaccine research when the Pfizer COVID-19 […]
August 11, 2021

Injectable Cabotegravir PrEP Superior to Oral TDF-FTC Injectable Cabotegravir PrEP Superior to Oral TDF-FTC

The future of preexposure prophylaxis (PrEP) is here, according to interim study results demonstrating the superiority of long-acting, injectable cabotegravir (CAB-LA) over the current workhorse, daily […]
August 3, 2021

New Guideline for Replacement ART: CAB/RPV LA Not for Everyone New Guideline for Replacement ART: CAB/RPV LA Not for Everyone

“One of the most important considerations before switching HIV patients to injectable long-acting cabotegravir/rilpivirine [CAB/RPV LA; Cabenuva, ViiV Healthcare] is for the patient and the clinician […]
July 29, 2021

Cryptococcal Meningitis: Single-Dose Regimen Noninferior Cryptococcal Meningitis: Single-Dose Regimen Noninferior

A single high dose of the antifungal agent liposomal amphotericin B (L-AmB; AmBisome, Gilead Sciences), with a background regimen of flucytosine and fluconazole, is noninferior and […]
July 28, 2021

Two-Drug Dolutegravir Treatment Noninferior to 3/4 Drug Regimen Two-Drug Dolutegravir Treatment Noninferior to 3/4 Drug Regimen

A two-drug fixed-dose tablet therapy of dolutegravir/lamivudine (Dovato, ViiV Healthcare; DTG/3TC) shows noninferiority in viral suppression among people with HIV-1 who switch from any type of […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0